Description
Using our intelligently designed and intuitive dataset, you can quickly understand how Viatris Inc. (VTRS) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.
Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.
For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.
Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.
Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:
1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.
2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.
3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).
4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.
5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).
6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).
7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).
Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].
Frequently Asked Questions
What is Viatris Inc. (VTRS) lobbying for?
Summary of Viatris Inc.’s Lobbying Data:
– Lobbying firms hired: Ferox Strategies, West Front Strategies Llc, Blue Ridge Law & Policy, P.C.
– General issues they lobbied on: Labor Issues/Antitrust/Workplace, Pharmacy, Health Issues, Financial Institutions/Investments/Securities, Medicare/Medicaid, Copyright/Patent/Trademark, Budget/Appropriations
– Specific issues they lobbied on: increasing transparency in generic drug applications, patent policy, corporate governance, drug pricing, pharmaceutical supply chain, FDA facility inspections, access to biosimilar biological products in Medicare, Medicaid rebate provision, generic drug approval process, agriculture appropriations, and more.
– Government agencies they lobbied: Patent & Trademark Office (PTO), House of Representatives, Securities & Exchange Commission (SEC), Department of Health & Human Services (HHS), Senate.
One could infer that Viatris Inc. is lobbying on these issues in order to protect and advance their interests in the pharmaceutical industry. Some of the specific issues they lobbied on, such as drug pricing, patent policy, and access to biosimilar biological products in Medicare, directly affect their business and profits. Lobbying on corporate governance issues could help them maintain their control over the corporation, while lobbying on FDA facility inspections and pharmaceutical supply chain issues could help them ensure the safety and quality of their products. Additionally, lobbying on budget and appropriations issues could help them secure funding and support for their research and development initiatives.
